Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.80 |
| ▸ | CA9 | Q16790 | 1/20 | 0.80 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.55 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15141411 | 1.00 | CA1 (0.80) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| Cycloheptanone SCHEMBL28237516 | 1.00 | CA1 (0.80) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| SCHEMBL5243566 | 1.00 | CA1 (0.80) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| SCHEMBL17515063 | 1.00 | CA1 (0.80) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| SCHEMBL13317121 | 1.00 | CA1 (0.80) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| SCHEMBL30742652 | 0.97 | CA1 (0.84) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| SCHEMBL2562226 | 0.95 | CA1 (0.71) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| Cyclohexanone SCHEMBL9561320 | 0.95 | CA1 (0.71) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| SCHEMBL2348331 | 0.95 | CA1 (0.71) | CA1CA9TRIM24TRIM33ALDH1A1 | |
| SCHEMBL27861332 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118221630-A | Continuous preparation method of epsilon-caprolactone | 湖南聚仁新材料股份公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-109503540-A | A kind of method preparing 6-caprolactone and its continuous production device | 黎明化工研究设计院有限责任公司 | 2019-03-22 | — | — | CN | disclosed |
| CN-105524037-B | A kind of method of oxidizing cyclohexanone | 中国石油化工股份有限公司 | 2018-11-30 | — | — | CN | disclosed |
| US-9944617-B2 | Selective aerobic oxidations using carbon nitride nanotubes | COUNCIL OF SCIENTIFIC AND INDUSTIAL RESEARCH (IN) | 2018-04-17 | — | — | US | disclosed |
| US-20160304484-A1 | SELECTIVE AEROBIC OXIDATIONS USING CARBON NITRIDE NANOTUBES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-10-20 | — | — | US | disclosed |
| WO-2015083185-A1 | SELECTIVE AEROBIC OXIDATIONS USING CARBON NITRIDE NANOTUBES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-06-11 | — | — | WO | disclosed |
| EP-2356226-A2 | NOVEL ENZYME | ISIS INNOVATION LIMITED (GB) | 2011-08-17 | — | — | EP | disclosed |
| WO-2010041055-A2 | NOVEL ENZYME | ISIS INNOVATION LIMITED (GB) | 2010-04-15 | — | — | WO | disclosed |
| US-5405974-A | Reacting a ketone, oxygen, an aromatic aldehyde using an aromatic solvent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304484-A1 | SELECTIVE AEROBIC OXIDATIONS USING CARBON NITRIDE NANOTUBES | FABP4, NOX4, HADHA | CA1 2045/4885CA9 1725/4885TRIM24 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.